title: Chronic Inflammatory Diseases and Endothelial Dysfunction.
abstract: Chronic inflammatory diseases are associated with increases in cardiovascular diseases (CVD) and subclinical atherosclerosis as well as early-stage endothelial dysfunction screening using the FMD method (Flow Mediated Dilation). This phenomenon, referred to as accelerated pathological remodeling of arterial wall, could be attributed to traditional risk factors associated with atherosclerosis. Several new non-invasive techniques have been used to study arterial wall's structural and functional alterations. These techniques (based of Radio Frequency, RF) allow for an assessment of artery age through calculations of intima-media thickness (RF- QIMT), pulse wave rate (RF- QAS) and endothelial dysfunction degree (FMD). The inflammatory and autoimmune diseases should now be considered as new cardiovascular risk factors, result of the major consequences of oxidative stress and RAS (Renin Angiotensin System) imbalance associated with the deleterious effect of known risk factors that lead to the alteration of the arterial wall. Inflammation plays a key role in all stages of the formation of vascular lesions maintained and exacerbated by the risk factors. The consequence of chronic inflammation is endothelial dysfunction that sets in and we can define it as an integrated marker of the damage to arterial walls by classic risk factors. The atherosclerosis, which develops among these patients, is the main cause for cardiovascular morbi-mortality and uncontrolled chronic biological inflammation, which quickly favors endothelial dysfunction. These inflammatory and autoimmune diseases should now be considered as new cardiovascular risk factors.
authors.affiliation: Privat Hospital, Athis Mons, 91200 Athis-Mons, Paris, France.
authors.forename: Xavier
authors.initials: X
authors.lastname: Castellon
authors.affiliation: Privat Hospital, Athis Mons, 91200 Athis-Mons, Paris, France.
authors.forename: Vera
authors.initials: V
authors.lastname: Bogdanova
keywords: FMD; atherosclerosis; endothelial dysfunction; inflammatory diseases; non-invasive artery age testing methods
references.citation: J Hypertens. 2006 Jun;24(6):983-91
references.pmid: 16685192
references.citation: Atherosclerosis. 2003 Oct;170(2):191-203
references.pmid: 14612198
references.citation: Cerebrovasc Dis. 2004;18(4):346-9
references.pmid: 15523176
references.citation: J Am Coll Cardiol. 2013 Feb 12;61(6):682-4
references.pmid: 23391201
references.citation: Am J Respir Crit Care Med. 2005 Sep 1;172(5):613-8
references.pmid: 15901608
references.citation: J Am Coll Cardiol. 2003 Apr 16;41(8):1387-93
references.pmid: 12706936
references.citation: Curr Opin Lipidol. 2009 Oct;20(5):409-14
references.pmid: 19644366
references.citation: Med Hypotheses. 2004;62(4):499-506
references.pmid: 15050096
references.citation: Circulation. 1995 May 1;91(9):2488-96
references.pmid: 7729036
references.citation: J Am Coll Cardiol. 2003 Oct 1;42(7):1149-60
references.pmid: 14522472
references.citation: Mayo Clin Proc. 2000 Apr;75(4):369-80
references.pmid: 10761492
references.citation: Autoimmun Rev. 2006 Jan;5(1):55-63
references.pmid: 16338212
references.citation: Br J Pharmacol. 2000 Jul;130(5):963-74
references.pmid: 10882379
references.citation: Arthritis Rheum. 2004 Jan;50(1):151-9
references.pmid: 14730611
references.citation: Circulation. 2000 Jul 4;102(1):42-7
references.pmid: 10880413
references.citation: Int J Clin Pract. 2005 Apr;59(4):462-72
references.pmid: 15853866
references.citation: Hypertension. 2001 Dec 1;38(6):1382-7
references.pmid: 11751722
references.citation: Cardiovasc Res. 2010 May 1;86(2):236-42
references.pmid: 20164116
references.citation: Pathophysiology. 2006 Aug;13(3):129-42
references.pmid: 16757157
references.citation: IEEE Trans Ultrason Ferroelectr Freq Control. 2006 Apr;53(4):724-34
references.pmid: 16615576
references.citation: Am J Cardiol. 1995 Feb 23;75(6):67B-70B
references.pmid: 7532351
references.citation: Int J Clin Pract. 2008 Aug;62(8):1246-54
references.pmid: 18564201
references.citation: JACC Cardiovasc Imaging. 2012 Mar;5(3):305-16
references.pmid: 22421178
references.citation: Circulation. 2005 Nov 22;112(21):3337-47
references.pmid: 16301360
references.citation: Circulation. 2003 Mar 11;107(9):1303-7
references.pmid: 12628952
references.citation: Stroke. 2012 Nov;43(11):2942-7
references.pmid: 22949478
references.citation: Histol Histopathol. 2008 Mar;23(3):381-90
references.pmid: 18072094
references.citation: Lab Invest. 2005 Jan;85(1):9-23
references.pmid: 15568038
references.citation: J Am Coll Cardiol. 2006 May 16;47(10 ):1967-75
references.pmid: 16697312
references.citation: BMJ. 2003 Nov 29;327(7426):1267
references.pmid: 14644971
references.citation: Circulation. 2004 Jul 27;110(4):380-5
references.pmid: 15262834
references.citation: Circ Res. 2007 Aug 3;101(3):e11-30
references.pmid: 17641228
references.citation: Clin Interv Aging. 2013;8:573-80
references.pmid: 23761967
references.citation: Physiol Rev. 2004 Oct;84(4):1381-478
references.pmid: 15383655
references.citation: Arthritis Rheum. 2008 Mar;58(3):835-42
references.pmid: 18311797
references.citation: J Clin Invest. 1999 Jun;103(11):1597-604
references.pmid: 10359569
references.citation: J Am Coll Cardiol. 2006 Apr 18;47(8 Suppl):C7-12
references.pmid: 16631513
references.citation: Endocr Rev. 2001 Feb;22(1):36-52
references.pmid: 11159815
references.citation: Thromb Haemost. 1993 Sep 1;70(3):380-5
references.pmid: 8259533
references.citation: Lupus. 2005;14(9):736-41
references.pmid: 16218478
references.citation: Ann N Y Acad Sci. 2005 Jun;1051:313-22
references.pmid: 16126973
references.citation: Annu Rev Genomics Hum Genet. 2004;5:189-218
references.pmid: 15485348
references.citation: Hypertension. 2001 Sep;38(3 Pt 2):581-7
references.pmid: 11566935
references.citation: Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1384-91
references.pmid: 23580143
references.citation: Arterioscler Thromb Vasc Biol. 1998 Sep;18(9):1359-62
references.pmid: 9743222
references.citation: Diabetes Care. 2003 Apr;26(4):1251-7
references.pmid: 12663606
references.citation: Semin Arthritis Rheum. 2008 Jun;37(6):373-80
references.pmid: 17977581
references.citation: Vasc Health Risk Manag. 2007;3(3):343-9
references.pmid: 17703642
references.citation: Ann Rheum Dis. 2003 Nov;62(11):1071-7
references.pmid: 14583570
references.citation: Nihon Rinsho. 2011 Jan;69(1):144-50
references.pmid: 21226275
references.citation: Lijec Vjesn. 2001 Jan-Feb;123(1-2):26-31
references.pmid: 11379194
references.citation: Am J Hypertens. 2011 Jan;24(1):5-17
references.pmid: 20940710
references.citation: Circ Res. 2001 Feb 2;88(2):E14-22
references.pmid: 11157681
references.citation: Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H435-46
references.pmid: 15277186
references.citation: Rejuvenation Res. 2008 Apr;11(2):393-8
references.pmid: 18393653
references.citation: Exp Physiol. 2005 Jul;90(4):449-55
references.pmid: 15890798
references.citation: Int Urol Nephrol. 2013 Dec;45(6):1605-12
references.pmid: 23483304